Abstract
Purpose
The purpose of this work was to investigate the mechanisms of cocrystal formation during cogrinding and storage of solid reactants, and to establish the effects of water by cogrinding with hydrated form of reactants and varying RH conditions during storage.
Methods
The hydrogen bonded 1:1 carbamazepine–saccharin cocrystal (CBZ–SAC) was used as a model compound. Cogrinding of solid reactants was studied under ambient and cryogenic conditions. The anhydrous, CBZ (III), and dihydrate forms of CBZ were studied. Coground samples were stored at room temperature at 0% and 75% RH. Samples were analyzed by XRPD, FTIR and DSC.
Results
Cocrystals prepared by cogrinding and during storage were similar to those prepared by solvent methods. The rate of cocrystallization was increased by cogrinding the hydrated form of CBZ and by increasing RH during storage. Cryogenic cogrinding led to higher levels of amorphization than room temperature cogrinding. The amorphous phase exhibited a T g around 41°C and transformed to cocrystal during storage.
Conclusions
Amorphous phases generated by pharmaceutical processes lead to cocrystal formation under conditions where there is increased molecular mobility and complementarity. Water, a potent plasticizer, enhances the rate of cocrystallization. This has powerful implications to control process induced transformations.
Similar content being viewed by others
References
C. B. Aakeroy and D. J. Salmon. Building co-crystals with molecular sense and supramolecular sensibility. Cryst. Eng. Comm. 7:439–44668 (2005).
G. Bettinetti, M. Caira, A. Callegari, M. Merli, M. Sorrenti, and C. Tadini. Structure and solid-state chemistry of anhydrous and hydrated crystal forms of the trimethoprim–sulfamethoxypyridazine 1:1 molecular complex. J. Pharm. Sci. 89:478–488 (2000).
M. R. Caira. Molecular complexes of sulfonamides. 2. 1/1 complexes between drug molecules — sulfadimidine acetylsalicylic acid and sulfadimidine-4-aminosalicylic acid. J. Crystallogr. Spectrosc. Res. 22:193–200 (1992).
M. R. Caira, L. R. Nassimbeni, and A. F. Wildervanck. Selective formation of hydrogen bonded cocrystals between sulfonamide and aromatic carboxylic acids in the solid state. J. Chem. Soc., Perkin Trans. 2:2213–2216 (1995).
G. R. Desiraju. Hydrogen bridges in crystal engineering: interactions without borders. Acc. Chem. Res. 35:565–573 (2002).
M. C. Etter. Hydrogen bonds as design elements in organic chemistry. J. Phys. Chem. 95:4601–4610 (1991).
M. C. Etter and G. M. Frankenbach. Hydrogen-bond directed cocrystallization as a tool for designing acentric organic solids. Chem. Mater. 1:10–12 (1989).
M. C. Etter and S. M. Reutzel. Hydrogen-bond directed cocrystallization and molecular recognition properties of acyclic imides. J. Am. Chem. Soc. 113:2586–2598 (1991).
M. C. Etter, S. M. Reutzel, and C. G. Choo. Self-organization of adenine and thymine in the solid state. J. Am. Chem. Soc. 115:4411–4412 (1993).
M. C. Etter, Z. Urbanczyk-Lipkowska, M. Zia-Ebrahimi, and T. W. Panunto. Hydrogen bond directed cocrystallization and molecular recognition properties of diarylureas. J. Am. Chem. Soc. 112:8415–8426 (1990).
A. Nangia and G. R. Desiraju. Supramolecular structures — reason and imagination. Acta Crystallogr. A54: 934–944 (1998).
B. Rodríguez-Spong, C. P. Price, A. Jayasankar, A. J. Matzger, and N. Rodríguez-Hornedo. General principles of pharmaceutical solid polymorphism: a supramolecular perspective. Adv. Drug Deliv. Rev. 56:241–274 (2004).
N. Rodríguez-Hornedo, S. J. Nehm, and A. Jayasankar. Cocrystals: Design, Properties and Formation Mechanisms, Encyclopedia of Pharmaceutical Technology, 2006 (in press).
B. Rodríguez-Spong. Enhancing the Pharmaceutical Behavior of Poorly Soluble Drugs Through the Formation of Cocrystals and Mesophases, Ph.D. Thesis, University of Michigan, 2005.
B. Rodríguez-Spong, P. Zocharski, J. Billups, J. McMahon, M. J. Zaworotko, and N. Rodríguez-Hornedo. Enhancing the Pharmaceutical Behavior of Carbamazepine Through the Formation of Cocrystals. AAPS J. 5:Abstract M1298 (2003).
A. V. Trask, W. D. S. Motherwell, and W. Jones. Pharmaceutical cocrystallization: engineering a remedy for caffeine hydration. Cryst. Growth Des. 5:1013–1021 (2005).
V. R. Pedireddi, W. Jones, A. P. Chorlton, and R. Docherty. Creation of crystalline supramolecular arrays: a comparison of co-crystal formation from solution and by solid state grinding. Chem. Commun. 8:987–988 (1996).
A. V. Trask, W. D. S. Motherwell, and W. Jones. Solvent-Drop Grinding: Green Polymorph Control of Cocrystallisation. Chem. Commun. 7:890–891 (2004).
S. L. Morissette, Ö. Almarsson, M. L. Peterson, J. F. Remenar, M. J. Read, A. V. Lemmo, S. Ellis, M. J. Cima, and C. R. Gardner. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv. Drug Deliv. Rev. 56:275–300 (2004).
S. J. Nehm, N. Rodríguez-Hornedo, and B. Rodríguez-Spong. Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation. Cryst. Growth Des. 6:592–600 (2005).
N. Rodríguez-Hornedo, S. J. Nehm, K. F. Seefeldt, Y. Pagan-Torres, and C. J. Falkiewicz. Reaction crystallization of pharmaceutical molecular complexes. Mol. Pharmacol. 3:362–367 (2006).
M. C. Etter, G. M. Frankenbach, and D. A. Adsmond. Using hydrogen bonds to design acentric organic materials for nonlinear optical users. Mol. Cryst. Liq. Cryst. 187:25–39 (1990).
K. J. Crowley and G. Zografi. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability. J. Pharm. Sci. 91:492–507 (2002).
D. Murphy, F. Rodríguez-Cintron, B. Langevin, R. C. Kelly, and N. Rodríguez-Hornedo. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. Int. J. Pharm. 246:121–134 (2002).
T. Oguchi, Y. Tozuka, T. Hanawa, M. Mizutani, N. Sasaki, S. Limmatvapirat, and K. Yamamoto. Elucidation of Solid-State Complexation in Ground Mixtures of Cholic Acid and Guest Compounds. Chem. Pharm. Bull. 50:887–891 (2002).
T. Oguchi, K. Kazama, T. Fukami, E. Yonemochi, and K. Yamamoto. Specific complexation of ursodeoxycholic acid with guest compounds induced by co-grinding. II. Effect of grinding temperature on the mechanochemical complexation. Bull. Chem. Soc. Jpn. 76:515–521 (2003).
M. Otsuka, T. Matsumoto, and N. Kaneniwa. Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding. Chem. Pharm. Bull. 34:1784–1793 (1986).
M. Otsuka, T. Ofusa, and Y. Matsuda. Effect of environmental humidity on the transformation pathway of carbamazepine polymorphic modifications during grinding. Colloids Surf., B Biointerfaces 13:263–273 (1999).
B. C. Hancock and G. Zografi. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm. Res. 11:471–477 (1994).
V. Andronis, M. Yoshioka, and G. Zografi. Effects of sorbed water on the crystallization of indomethacin from the amorphous state. J. Pharm. Sci. 86:346–351 (1997).
S. G. Fleischman, S. S. Kuduva, J. A. McMahon, B. Moulton, R. D. B. Walsh, N. Rodríguez-Hornedo, and M. J. Zaworotko. Crystal engineering of the composition of pharmaceutical phases: multiple-component crystalline solids involving carbamazepine. Cryst. Growth Des. 3:909–919 (2003).
A. Jayasankar, A. Somwangthanaroj, B. Sirinutsomboon, Z. J. Shao, and N. Rodríguez-Hornedo. Cocrystal formation by solid-state grinding and during storage. AAPS J. 6:R6159 (2004).
K. Seefeldt, J. Miller, S. Ding, and N. Rodríguez-Hornedo. Crystallization of carbamazepine–nicotinamide cocrystal from the amorphous phase. AAPS J. 6:R6172 (2004).
F. E. M. O’Brien. The control of humidity using saturated salt solutions. J. Sci. Instrum. 25:73–76 (1948).
A. Salari and R. E. Young. Application of attenuated total reflectance FTIR spectroscopy to the analysis of mixtures of pharmaceutical polymorphs. Int. J. Pharm. 163:157–166 (1998).
A. D. Patel, P. E. Luner, and M. S. Kemper. Quantitative analysis of polymorphs in binary and multi-component powder mixtures by near-infrared reflectance spectroscopy. Int. J. Pharm. 206:63–74 (2000).
R. Nair, N. Nyamweya, S. Gonen, L. J. Martinez-Miranda, and S. W. Hoag. Influence of various drugs on the glass transition temperature of poly(Vinylpyrrolidone): a thermodynamic and spectroscopic investigation. Int. J. Pharm. 225:83–96 (2001).
N. B. Colthup, L. H. Daly, and S. E. Wiberley. Introduction to Infrared and Raman Spectroscopy. Harcourt Brace, Boston, 1990.
D. W. Mayo, F. A. Miller, and R. W. Hannah. Course Notes on the Interpretation of Infrared and Raman Spectra. Wiley, Hoboken, NJ, 2004.
Y. Hase. The infrared and Raman spectra of phthalimide, N–D-phthalimide and potassium phthalimide. J. Mol. Struct. 48:33–42 (1978).
G. Jovanovski. Metal saccharinates and their complexes with N-donor ligands. CCACAA 73:843–868 (2000).
S. M. Teleb. Spectral and thermal studies of saccharinato complexes. J. Argent. Chem. Soc. 92:31–40 (2004).
G. Jovanovski, S. Tanceva, and B. Soptrajanov. The SO2 stretching vibrations in some metal saccharinates: spectra–structure correlations. Spectrosc. Lett. 28:1095–1109 (1995).
R. J. Behme and D. Brooke. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. J. Pharm. Sci. 80:986–990 (1991).
B. Hancock, S. Shamblin, and G. Zografi. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm. Res. 12:799–806 (1995).
A. Trask and W. Jones. Crystal engineering of organic cocrystals by the solid-state grinding approach. Top. Curr. Chem. 254:41–70 (2005).
H. A. Schneider. The Gordon–Taylor equation. Additivity and interaction in compatible polymer blends. Makromol. Chem. 189:1941–1955 (1988).
P. Tong and G. Zografi. A study of amorphous molecular dispersions of indomethacin and its sodium salt. J. Pharm. Sci. 90:1991–2004 (2001).
L. S. Taylor and G. Zografi. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14:1691–1698 (1997).
M. K. Gupta, A. Vanwert, and R. H. Bogner. Formation of physically stable amorphous drugs by milling with neusilin. J. Pharm. Sci. 92:536–551 (2003).
Acknowledgments
We acknowledge Bei Huang for technical assistance with XRPD and FTIR analysis. We gratefully acknowledge funding from Pfizer, Inc., Ann Arbor, MI, and from the Purdue/Michigan Consortium on the Physical and Chemical Stability of Pharmaceutical Solids.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jayasankar, A., Somwangthanaroj, A., Shao, Z.J. et al. Cocrystal Formation during Cogrinding and Storage is Mediated by Amorphous Phase. Pharm Res 23, 2381–2392 (2006). https://doi.org/10.1007/s11095-006-9110-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-9110-6